4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-031264
Chief Financial Officer gave up 1,639 shares (to pay taxes)
- Chief Financial Officer acquired 4,206 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Option exercise | +1,752 | 109,953 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Shares withheld for taxes | −683 | $6.69 | $4,569 | 109,270 | D |
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Option exercise | +2,454 | 111,724 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Shares withheld for taxes | −956 | $6.69 | $6,396 | 110,768 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Option exercise · Restricted Stock Units | −1,752 | 18,698 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-05-18 | Option exercise · Restricted Stock Units | −2,454 | 56,452 | D | ||
Loading xslF345X04/doc4.xml…